Cervical Cancer Screening Among Women Living with HIV: a Cross-sectional Study Using the Baseline Questionnaire Data from the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS)

Overview

Journal CMAJ Open

Specialty General Medicine

Date 2019 Apr 14

PMID 30979726

Citations 8

Authors

Alexandra de Pokomandy

Ann N Burchell

Kate Salters

Erin Ding

Nadia OBrien

Dada Mamvula Bakombo

Karene Proulx-Boucher

Isabelle Boucoiran

Neora Pick

Gina Ogilvie

Mona Loutfy

Angela Kaida

Affiliations

Soon will be listed here.

Abstract

Background: Cisgender women with HIV experience an elevated risk of cervical cancer compared with HIV-negative women, but this cancer can be prevented through regular cervical cancer screening. Our study objective was to measure adherence to current national cervical cancer screening guidelines among women with HIV in 3 Canadian provinces and identify factors associated with delays.

Methods: We conducted a cross-sectional study using the baseline questionnaire of the Canadian HIV Women's Sexual and Reproductive Health Cohort Study (CHIWOS). Participants were recruited through clinics, peers and community organizations in British Columbia, Ontario and Quebec. Women were eligible for inclusion if they were cisgender female with HIV, aged 21-70 years, and never had cervicectomy/hysterectomy.

Results: Of 1189 eligible participants, 815 (68.5%) had received cervical cancer screening less than 1 year ago (i.e., as recommended), 211 (17.7%) 1-3 years ago (i.e., moderate delay) and 163 (13.7%) at least 3 years ago or never (i.e., long delay). Overall, 309 (26.0%) had never discussed the need for a Papanicolaou smear with a nurse/doctor. Factors associated with a long delay were living in Ontario (adjusted odds ratio [OR] 2.51, 95% confidence interval [CI] 1.29-4.88) or Quebec (adjusted OR 3.70, 95% CI 1.79-7.67) (v. BC), being sexually inactive in the past 6 months (adjusted OR 2.02, 95% CI 1.25-3.25), having unknown or < 200 cells/mm CD4 counts (adjusted OR 1.78, 95% CI 1.11-2.85) and having a male HIV care provider (adjusted OR 2.15, 95% CI 1.36-3.42).

Interpretation: Over one-third of women reported cervical cancer screening delays, and one-quarter had never discussed cervical cancer screening recommendations with a health care provider. Additional efforts are needed to improve women's and health care providers' awareness of cervical cancer screening recommendations, particularly among women who are sexually inactive, who are immunosuppressed and who have male HIV care providers.

Citing Articles

Barriers Associated with Adherence to Cervical Cancer Screening Among Women Living with HIV in Nkhatabay District, Malawi: A Mixed-Methods Study.

Baluwa P, Moyo R, Baluwa M, Nyirenda L Int J Womens Health. 2024; 16:491-507.

PMID: 38524242 PMC: 10961009. DOI: 10.2147/IJWH.S442522.

Dissemination of the Women-Centred HIV Care Model: A Multimodal Process and Evaluation.

Koebel J, Kazemi M, Kennedy V, Medeiros P, Bertozzi B, Bevan L J Int Assoc Provid AIDS Care. 2024; 23:23259582231226036.

PMID: 38389331 PMC: 10894538. DOI: 10.1177/23259582231226036.

A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV.

Cvetkovic A, King E, Skerritt L, Loutfy M, Tseng A, Murray M J Assoc Med Microbiol Infect Dis Can. 2022; 6(4):278-295.

PMID: 36338461 PMC: 9629258. DOI: 10.3138/jammi-2021-0014.

Prevalence of Physical Health, Mental Health, and Disability Comorbidities among Women Living with HIV in Canada.

Heer E, Kaida A, OBrien N, Kleiner B, Pierre A, Rouleau D J Pers Med. 2022; 12(8).

PMID: 36013243 PMC: 9409885. DOI: 10.3390/jpm12081294.

Factors and Priorities Influencing Satisfaction with Care among Women Living with HIV in Canada: A Fuzzy Cognitive Mapping Study.

Skerritt L, Kaida A, Savoie E, Sanchez M, Sarmiento I, OBrien N J Pers Med. 2022; 12(7).

PMID: 35887575 PMC: 9320512. DOI: 10.3390/jpm12071079.

References

Frisch M, Biggar R, Goedert J . Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000; 92(18):1500-10. DOI: 10.1093/jnci/92.18.1500. View

Ahdieh L, Klein R, Burk R, Cu-Uvin S, Schuman P, Duerr A . Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001; 184(6):682-90. DOI: 10.1086/323081. View

Laga M, Icenogle J, Marsella R, Manoka A, Nzila N, Ryder R . Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection. Int J Cancer. 1992; 50(1):45-8. DOI: 10.1002/ijc.2910500110. View

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

Shuter J, Kalkut G, Pinon M, Bellin E, Zingman B . A computerized reminder system improves compliance with Papanicolaou smear recommendations in an HIV care clinic. Int J STD AIDS. 2003; 14(10):675-80. DOI: 10.1258/095646203322387938. View

Clifford G, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A . Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97(6):425-32. DOI: 10.1093/jnci/dji072. View

Strickler H, Burk R, Fazzari M, Anastos K, Minkoff H, Massad L . Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005; 97(8):577-86. DOI: 10.1093/jnci/dji073. View

Petignat P, Hankins C, Walmsley S, Money D, Provencher D, Pourreaux K . Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women. Clin Infect Dis. 2005; 41(4):527-34. DOI: 10.1086/432059. View

Kitchener H, Castle P, Cox J . Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine. 2006; 24 Suppl 3:S3/63-70. DOI: 10.1016/j.vaccine.2006.05.113. View

10.

Clifford G, Goncalves M, Franceschi S . Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006; 20(18):2337-44. DOI: 10.1097/01.aids.0000253361.63578.14. View

11.

Keiser O, Martinez de Tejada B, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel A . Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006; 43(5):550-5. DOI: 10.1097/01.qai.0000245884.66509.7a. View

12.

. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356(19):1915-27. DOI: 10.1056/NEJMoa061741. View

13.

Koethe J, Moore R, Wagner K . Physician specialization and women's primary care services in an urban HIV clinic. AIDS Patient Care STDS. 2008; 22(5):373-80. PMC: 2597508. DOI: 10.1089/apc.2007.0032. View

14.

Oster A, Sullivan P, Blair J . Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009; 51(4):430-6. DOI: 10.1097/QAI.0b013e3181acb64a. View

15.

Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch M . The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol. 1991; 164(2):593-9. DOI: 10.1016/s0002-9378(11)80029-3. View

16.

Fonquernie F, Lacombe K, Vincensini J, Boccara F, Clozel S, Ayouch Boda A . How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program. AIDS Care. 2010; 22(5):588-96. DOI: 10.1080/09540120903280893. View

17.

Dal Maso L, Franceschi S, Lise M, Sassoli de Bianchi P, Polesel J, Ghinelli F . Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010; 10:310. PMC: 2904281. DOI: 10.1186/1471-2407-10-310. View

18.

Leece P, Kendall C, Touchie C, Pottie K, Angel J, Jaffey J . Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician. 2011; 56(12):e425-31. PMC: 3001950. View

19.

Wikstrom I, Lindell M, Sanner K, Wilander E . Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011; 105(3):337-9. PMC: 3172898. DOI: 10.1038/bjc.2011.236. View

20.

Baranoski A, Horsburgh C, Cupples L, Aschengrau A, Stier E . Risk factors for nonadherence with Pap testing in HIV-infected women. J Womens Health (Larchmt). 2011; 20(11):1635-43. PMC: 3216072. DOI: 10.1089/jwh.2010.2465. View